These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 29388043

  • 1. Longitudinal AddiQoL scores may identify higher risk for adrenal crises in Addison's disease.
    Meyer G, Koch M, Herrmann E, Bojunga J, Badenhoop K.
    Endocrine; 2018 May; 60(2):355-361. PubMed ID: 29388043
    [Abstract] [Full Text] [Related]

  • 2. Quality of life in European patients with Addison's disease: validity of the disease-specific questionnaire AddiQoL.
    Øksnes M, Bensing S, Hulting AL, Kämpe O, Hackemann A, Meyer G, Badenhoop K, Betterle C, Parolo A, Giordano R, Falorni A, Papierska L, Jeske W, Kasperlik-Zaluska AA, Chatterjee VK, Husebye ES, Løvås K.
    J Clin Endocrinol Metab; 2012 Feb; 97(2):568-76. PubMed ID: 22090270
    [Abstract] [Full Text] [Related]

  • 3. Development of a disease-specific quality of life questionnaire in Addison's disease.
    Løvås K, Curran S, Oksnes M, Husebye ES, Huppert FA, Chatterjee VK.
    J Clin Endocrinol Metab; 2010 Feb; 95(2):545-51. PubMed ID: 20016050
    [Abstract] [Full Text] [Related]

  • 4. Decreased physical activity, reduced QoL and presence of debilitating fatigue in patients with Addison's disease.
    van der Valk ES, Smans LC, Hofstetter H, Stubbe JH, de Vries M, Backx FJ, Hermus AR, Zelissen PM.
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):354-60. PubMed ID: 26953557
    [Abstract] [Full Text] [Related]

  • 5. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
    Gagliardi L, Nenke MA, Thynne TR, von der Borch J, Rankin WA, Henley DE, Sorbello J, Inder WJ, Torpy DJ.
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
    [Abstract] [Full Text] [Related]

  • 6. Health-Related Quality of Life in Patients with Primary Adrenal Insufficiency.
    Zdrojowy-Wełna A, Stańska A, Halupczok-Żyła J, Szcześniak D, Bolanowski M.
    J Clin Med; 2023 Nov 22; 12(23):. PubMed ID: 38068288
    [Abstract] [Full Text] [Related]

  • 7. Altered biomarkers for cardiovascular disease and inflammation in autoimmune Addison's disease - a cross-sectional study.
    Sævik ÅB, Ueland G, Åkerman AK, Methlie P, Quinkler M, Jørgensen AP, Höybye C, Debowska AWJ, Nedrebø BG, Dahle AL, Carlsen S, Tomkowicz A, Sollid ST, Nermoen I, Grønning K, Dahlqvist P, Grimnes G, Skov J, Finnes T, Valland SF, Wahlberg J, Holte SE, Kämpe O, Bensing S, Husebye ES, Øksnes M.
    Eur J Endocrinol; 2023 Oct 17; 189(4):438-447. PubMed ID: 37807083
    [Abstract] [Full Text] [Related]

  • 8. Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: the CORTI-COVID study.
    Martino M, Aboud N, Cola MF, Giancola G, Ciarloni A, Salvio G, Arnaldi G.
    J Endocrinol Invest; 2021 May 17; 44(5):1075-1084. PubMed ID: 32946078
    [Abstract] [Full Text] [Related]

  • 9. Sex-Specific Limitations in Physical Health in Primary Adrenal Insufficiency.
    Didriksen NM, Sævik ÅB, Sortland LS, Øksnes M, Husebye ES.
    Front Endocrinol (Lausanne); 2021 May 17; 12():718660. PubMed ID: 34733237
    [Abstract] [Full Text] [Related]

  • 10. Adherence to glucocorticoid replacement therapy in Addison's disease: Association with patients' disease knowledge and quality of life.
    Yazidi M, Salem MB, Oueslati I, Khessairi N, Chaker F, Chihaoui M.
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Oct 17; 70(8):532-539. PubMed ID: 38783727
    [Abstract] [Full Text] [Related]

  • 11. Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.
    Giordano R, Guaraldi F, Marinazzo E, Fumarola F, Rampino A, Berardelli R, Karamouzis I, Lucchiari M, Manetta T, Mengozzi G, Arvat E, Ghigo E.
    Endocrine; 2016 Feb 17; 51(2):360-8. PubMed ID: 26184416
    [Abstract] [Full Text] [Related]

  • 12. Acute illness in patients with concomitant Addison's disease and type 1 diabetes mellitus: Increased incidence of hypoglycaemia and adrenal crises.
    Mortimer B, Naganur VD, Satouris P, Greenfield JR, Torpy DJ, Rushworth RL.
    Clin Endocrinol (Oxf); 2020 Aug 17; 93(2):104-110. PubMed ID: 32396991
    [Abstract] [Full Text] [Related]

  • 13. What affects the quality of life in autoimmune Addison's disease?
    Meyer G, Hackemann A, Penna-Martinez M, Badenhoop K.
    Horm Metab Res; 2013 Feb 17; 45(2):92-5. PubMed ID: 23322510
    [Abstract] [Full Text] [Related]

  • 14. Addison's disease with polyglandular autoimmunity carries a more than 2·5-fold risk for adrenal crises: German Health insurance data 2010-2013.
    Meyer G, Badenhoop K, Linder R.
    Clin Endocrinol (Oxf); 2016 Sep 17; 85(3):347-53. PubMed ID: 26896640
    [Abstract] [Full Text] [Related]

  • 15. Adrenal crises in children with adrenal insufficiency: epidemiology and risk factors.
    Eyal O, Levin Y, Oren A, Zung A, Rachmiel M, Landau Z, Schachter-Davidov A, Segev-Becker A, Weintrob N.
    Eur J Pediatr; 2019 May 17; 178(5):731-738. PubMed ID: 30806790
    [Abstract] [Full Text] [Related]

  • 16. Clinical profile and prognosis of Addison's disease in India.
    Agarwal G, Bhatia E, Pandey R, Jain SK.
    Natl Med J India; 2001 May 17; 14(1):23-5. PubMed ID: 11242694
    [Abstract] [Full Text] [Related]

  • 17. Sleep disturbances in patients with Addison's disease.
    Løvås K, Husebye ES, Holsten F, Bjorvatn B.
    Eur J Endocrinol; 2003 Apr 17; 148(4):449-56. PubMed ID: 12656666
    [Abstract] [Full Text] [Related]

  • 18. Modified-release prednisone decreases complaints and fatigue compared to standard prednisolone in patients with adrenal insufficiency.
    Langenheim J, Ventz M, Hinz A, Quinkler M.
    Horm Metab Res; 2013 Feb 17; 45(2):96-101. PubMed ID: 22752958
    [Abstract] [Full Text] [Related]

  • 19. Poor quality of life, depressed mood, and memory impairment may be mediated by sleep disruption in patients with Addison's disease.
    Henry M, Wolf PS, Ross IL, Thomas KG.
    Physiol Behav; 2015 Nov 01; 151():379-85. PubMed ID: 26256520
    [Abstract] [Full Text] [Related]

  • 20. Sexuality and fertility in women with Addison's disease.
    Erichsen MM, Husebye ES, Michelsen TM, Dahl AA, Løvås K.
    J Clin Endocrinol Metab; 2010 Sep 01; 95(9):4354-60. PubMed ID: 20610594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.